Avid Bioservices Investor Relations Material
Latest events
Q1 2025
Avid Bioservices
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avid Bioservices Inc
Access all reports
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO) that provides specialized services for the biotechnology and biopharmaceutical industries. The company focuses on biologics, offering process development, clinical and commercial Current Good Manufacturing Practice (CGMP) manufacturing, and related services. These include bulk packaging, release and stability testing, regulatory support, upstream and downstream process optimization, analytical methods development, and cell line development. Avid supports projects from early preclinical stages to commercial-scale production. Its shares are listed on the NASDAQ.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
CDMO
Country
🇺🇸 United States